Live News Categoriesmarket

ONCUS (ONCUS) News

Follow ONCUS (ONCUS) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ONCUS Asset market Sector Markets 90 days 1 Updated Jul 07, 2026, 01:14 PM UTC Open live news feed

H BeOne Medicines price target raised to $416 from $413 at Truist Truist raised the firm's price target on BeOne Medicines to $416 from $413 and keeps a Buy rating on the shares as part of a broader research note previewing Q2 earnings in Biotech. The firm is anticipating a rebound fro EQUITY | Jul 07, 2026, 01:14 PM UTC